BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26585118)

  • 1. Aspirin Reduces Plasma Concentrations of the Oncometabolite 2-Hydroxyglutarate: Results of a Randomized, Double-Blind, Crossover Trial.
    Liesenfeld DB; Botma A; Habermann N; Toth R; Weigel C; Popanda O; Klika KD; Potter JD; Lampe JW; Ulrich CM
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):180-7. PubMed ID: 26585118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients.
    Petrera M; Paleari L; Clavarezza M; Puntoni M; Caviglia S; Briata IM; Oppezzi M; Mislej EM; Stabuc B; Gnant M; Bachleitner-Hofmann T; Roth W; Scherer D; Haefeli WE; Ulrich CM; DeCensi A
    BMC Cancer; 2018 Dec; 18(1):1210. PubMed ID: 30514262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Low-dose and Standard-dose Aspirin on PGE
    Drew DA; Schuck MM; Magicheva-Gupta MV; Stewart KO; Gilpin KK; Miller P; Parziale MP; Pond EN; Takacsi-Nagy O; Zerjav DC; Chin SM; Mackinnon Krems J; Meixell D; Joshi AD; Ma W; Colizzo FP; Carolan PJ; Nishioka NS; Staller K; Richter JM; Khalili H; Gala MK; Garber JJ; Chung DC; Yarze JC; Zukerberg L; Petrucci G; Rocca B; Patrono C; Milne GL; Wang M; Chan AT
    Cancer Prev Res (Phila); 2020 Oct; 13(10):877-888. PubMed ID: 32718943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics Analysis of Aspirin's Effects in Human Colon Tissue and Associations with Adenoma Risk.
    Barry EL; Fedirko V; Uppal K; Ma C; Liu K; Mott LA; Peacock JL; Passarelli MN; Baron JA; Jones DP
    Cancer Prev Res (Phila); 2020 Oct; 13(10):863-876. PubMed ID: 32655007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Metabolomics Analysis of Aspirin Treatment and Risk of Colorectal Adenomas.
    Barry EL; Fedirko V; Jin Y; Liu K; Mott LA; Peacock JL; Passarelli MN; Baron JA; Jones DP
    Cancer Prev Res (Phila); 2022 Aug; 15(8):521-531. PubMed ID: 35653338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial.
    Drew DA; Chin SM; Gilpin KK; Parziale M; Pond E; Schuck MM; Stewart K; Flagg M; Rawlings CA; Backman V; Carolan PJ; Chung DC; Colizzo FP; Freedman M; Gala M; Garber JJ; Huttenhower C; Kedrin D; Khalili H; Kwon DS; Markowitz SD; Milne GL; Nishioka NS; Richter JM; Roy HK; Staller K; Wang M; Chan AT
    Trials; 2017 Feb; 18(1):50. PubMed ID: 28143522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-treated healthy adult volunteers.
    Cryer B; Berlin RG; Cooper SA; Hsu C; Wason S
    Clin Ther; 2005 Feb; 27(2):185-91. PubMed ID: 15811481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction potential and tolerability of the coadministration of cilostazol and aspirin.
    Mallikaarjun S; Forbes WP; Bramer SL
    Clin Pharmacokinet; 1999; 37 Suppl 2():87-93. PubMed ID: 10702891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood levels of long-chain polyunsaturated fatty acids, aspirin, and the risk of colorectal cancer.
    Hall MN; Campos H; Li H; Sesso HD; Stampfer MJ; Willett WC; Ma J
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):314-21. PubMed ID: 17301265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.
    Cole BF; Baron JA; Sandler RS; Haile RW; Ahnen DJ; Bresalier RS; McKeown-Eyssen G; Summers RW; Rothstein RI; Burke CA; Snover DC; Church TR; Allen JI; Robertson DJ; Beck GJ; Bond JH; Byers T; Mandel JS; Mott LA; Pearson LH; Barry EL; Rees JR; Marcon N; Saibil F; Ueland PM; Greenberg ER;
    JAMA; 2007 Jun; 297(21):2351-9. PubMed ID: 17551129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology and cellular/molecular mechanisms of action of aspirin and non-aspirin NSAIDs in colorectal cancer.
    Schrör K
    Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):473-84. PubMed ID: 22122764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine Interaction with Aspirin: a Double-Blind, Crossover Trial in Healthy Volunteers.
    Bartko J; Schoergenhofer C; Schwameis M; Wadowski P; Kubica J; Jilma B; Hobl EL
    J Pharmacol Exp Ther; 2018 May; 365(2):430-436. PubMed ID: 29540563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
    Sandler RS
    Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial.
    Angiolillo DJ; Hwang C; Datto C; Desai B; Sostek M
    Clin Ther; 2011 Dec; 33(12):1883-93. PubMed ID: 22078153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring Differences in the Aspirin-Colorectal Cancer Association by Sex and Race/Ethnicity: The Multiethnic Cohort Study.
    Park SY; Wilkens LR; Kolonel LN; Monroe KR; Haiman CA; Marchand LL
    Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):162-169. PubMed ID: 27765797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS).
    Fedirko V; Bradshaw PT; Figueiredo JC; Sandler RS; Barry EL; Ahnen DJ; Milne GL; Bresalier RS; Baron JA
    Cancer Prev Res (Phila); 2015 Nov; 8(11):1061-8. PubMed ID: 26304466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.
    Flossmann E; Rothwell PM;
    Lancet; 2007 May; 369(9573):1603-13. PubMed ID: 17499602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet inhibitory effects of OTC doses of naproxen sodium compared with prescription dose naproxen sodium and low-dose aspirin.
    Schiff M; Hochberg MC; Oldenhof J; Brune K
    Curr Med Res Opin; 2009 Oct; 25(10):2471-7. PubMed ID: 19678751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of calcium supplementation on biomarkers of inflammation and oxidative stress in colorectal adenoma patients: a randomized controlled trial.
    Yang B; Gross MD; Fedirko V; McCullough ML; Bostick RM
    Cancer Prev Res (Phila); 2015 Nov; 8(11):1069-75. PubMed ID: 26304464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.
    Chan AT; Giovannucci EL; Meyerhardt JA; Schernhammer ES; Curhan GC; Fuchs CS
    JAMA; 2005 Aug; 294(8):914-23. PubMed ID: 16118381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.